These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 25642832)

  • 1. Identification of five chronic obstructive pulmonary disease subgroups with different prognoses in the ECLIPSE cohort using cluster analysis.
    Rennard SI; Locantore N; Delafont B; Tal-Singer R; Silverman EK; Vestbo J; Miller BE; Bakke P; Celli B; Calverley PM; Coxson H; Crim C; Edwards LD; Lomas DA; MacNee W; Wouters EF; Yates JC; Coca I; Agustí A;
    Ann Am Thorac Soc; 2015 Mar; 12(3):303-12. PubMed ID: 25642832
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification and prospective validation of clinically relevant chronic obstructive pulmonary disease (COPD) subtypes.
    Garcia-Aymerich J; Gómez FP; Benet M; Farrero E; Basagaña X; Gayete À; Paré C; Freixa X; Ferrer J; Ferrer A; Roca J; Gáldiz JB; Sauleda J; Monsó E; Gea J; Barberà JA; Agustí À; Antó JM;
    Thorax; 2011 May; 66(5):430-7. PubMed ID: 21177668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of five clusters of comorbidities in a longitudinal Japanese chronic obstructive pulmonary disease cohort.
    Chubachi S; Sato M; Kameyama N; Tsutsumi A; Sasaki M; Tateno H; Nakamura H; Asano K; Betsuyaku T;
    Respir Med; 2016 Aug; 117():272-9. PubMed ID: 27492541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A cluster analysis of chronic obstructive pulmonary disease in dusty areas cohort identified three subgroups.
    Kim S; Lim MN; Hong Y; Han SS; Lee SJ; Kim WJ
    BMC Pulm Med; 2017 Dec; 17(1):209. PubMed ID: 29246211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Examining the Effects of Age on Health Outcomes of Chronic Obstructive Pulmonary Disease: Results From the Genetic Epidemiology of Chronic Obstructive Pulmonary Disease Study and Evaluation of Chronic Obstructive Pulmonary Disease Longitudinally to Identify Predictive Surrogate Endpoints Cohorts.
    Parulekar AD; Martinez C; Tsai CL; Locantore N; Atik M; Yohannes AM; Kao CC; Al-Azzawi H; Mohsin A; Wise RA; Foreman MG; Demeo DL; Regan EA; Make BJ; Boriek AM; Wiener LE; Hanania NA
    J Am Med Dir Assoc; 2017 Dec; 18(12):1063-1068. PubMed ID: 29169736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clusters of comorbidities based on validated objective measurements and systemic inflammation in patients with chronic obstructive pulmonary disease.
    Vanfleteren LE; Spruit MA; Groenen M; Gaffron S; van Empel VP; Bruijnzeel PL; Rutten EP; Op 't Roodt J; Wouters EF; Franssen FM
    Am J Respir Crit Care Med; 2013 Apr; 187(7):728-35. PubMed ID: 23392440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ectopic fat accumulation in patients with COPD: an ECLIPSE substudy.
    Martin M; Almeras N; Després JP; Coxson HO; Washko GR; Vivodtzev I; Wouters EF; Rutten E; Williams MC; Murchison JT; MacNee W; Sin DD; Maltais F
    Int J Chron Obstruct Pulmon Dis; 2017; 12():451-460. PubMed ID: 28203068
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characteristics, stability and outcomes of the 2011 GOLD COPD groups in the ECLIPSE cohort.
    Agusti A; Edwards LD; Celli B; Macnee W; Calverley PM; Müllerova H; Lomas DA; Wouters E; Bakke P; Rennard S; Crim C; Miller BE; Coxson HO; Yates JC; Tal-Singer R; Vestbo J;
    Eur Respir J; 2013 Sep; 42(3):636-46. PubMed ID: 23766334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The importance of symptoms in the longitudinal variability of clusters in COPD patients: A validation study.
    de Torres JP; Marin JM; Martinez-Gonzalez C; de Lucas-Ramos P; Cosio B; Casanova C;
    Respirology; 2018 May; 23(5):485-491. PubMed ID: 29027309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Different Clusters in Patients with Chronic Obstructive Pulmonary Disease (COPD): A Two-Center Study in Brazil.
    Zucchi JW; Franco EAT; Schreck T; Castro E Silva MH; Migliorini SRDS; Garcia T; Mota GAF; de Morais BEB; Machado LHS; Batista ANR; de Paiva SAR; de Godoy I; Tanni SE
    Int J Chron Obstruct Pulmon Dis; 2020; 15():2847-2856. PubMed ID: 33192058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. One-year change in health status and subsequent outcomes in COPD.
    Wilke S; Jones PW; Müllerova H; Vestbo J; Tal-Singer R; Franssen FM; Agusti A; Bakke P; Calverley PM; Coxson HO; Crim C; Edwards LD; Lomas DA; MacNee W; Rennard SI; Yates JC; Wouters EF; Spruit MA
    Thorax; 2015 May; 70(5):420-5. PubMed ID: 25782757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factor analysis in predominantly severe COPD: identification of disease heterogeneity by easily measurable characteristics.
    Postma DS; Anzueto AR; Jenkins C; Make BJ; Similowski T; Östlund O; Eriksson GS; Calverley PM
    Respir Med; 2013 Dec; 107(12):1939-47. PubMed ID: 23953956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A simple algorithm for the identification of clinical COPD phenotypes.
    Burgel PR; Paillasseur JL; Janssens W; Piquet J; Ter Riet G; Garcia-Aymerich J; Cosio B; Bakke P; Puhan MA; Langhammer A; Alfageme I; Almagro P; Ancochea J; Celli BR; Casanova C; de-Torres JP; Decramer M; Echazarreta A; Esteban C; Gomez Punter RM; Han MK; Johannessen A; Kaiser B; Lamprecht B; Lange P; Leivseth L; Marin JM; Martin F; Martinez-Camblor P; Miravitlles M; Oga T; Sofia Ramírez A; Sin DD; Sobradillo P; Soler-Cataluña JJ; Turner AM; Verdu Rivera FJ; Soriano JB; Roche N;
    Eur Respir J; 2017 Nov; 50(5):. PubMed ID: 29097431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characteristics and outcomes of chronic obstructive pulmonary disease in never smokers in Denmark: a prospective population study.
    Thomsen M; Nordestgaard BG; Vestbo J; Lange P
    Lancet Respir Med; 2013 Sep; 1(7):543-50. PubMed ID: 24461615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An index of daily step count and systemic inflammation predicts clinical outcomes in chronic obstructive pulmonary disease.
    Moy ML; Teylan M; Danilack VA; Gagnon DR; Garshick E
    Ann Am Thorac Soc; 2014 Feb; 11(2):149-57. PubMed ID: 24308588
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cognitive function in chronic obstructive pulmonary disease: relationship to global initiative for chronic obstructive lung disease 2011 categories.
    Tulek B; Atalay NB; Yildirim G; Kanat F; Süerdem M
    Respirology; 2014 Aug; 19(6):873-80. PubMed ID: 24935516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyperpolarized (3)He ventilation defects used to predict pulmonary exacerbations in mild to moderate chronic obstructive pulmonary disease.
    Kirby M; Pike D; Coxson HO; McCormack DG; Parraga G
    Radiology; 2014 Dec; 273(3):887-96. PubMed ID: 24960283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Promise of Observational Studies (ECLIPSE, SPIROMICS, and COPDGene) in Achieving the Goal of Personalized Treatment of Chronic Obstructive Pulmonary Disease.
    Rennard SI
    Semin Respir Crit Care Med; 2015 Aug; 36(4):478-90. PubMed ID: 26238636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distribution, temporal stability and association with all-cause mortality of the 2017 GOLD groups in the ECLIPSE cohort.
    Faner R; Noell G; Badia JR; López-Giraldo A; Bakke P; Silverman EK; Tal-Singer R; Agustí A
    Respir Med; 2018 Aug; 141():14-19. PubMed ID: 30053959
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Should we view chronic obstructive pulmonary disease differently after ECLIPSE? A clinical perspective from the study team.
    Vestbo J; Agusti A; Wouters EF; Bakke P; Calverley PM; Celli B; Coxson H; Crim C; Edwards LD; Locantore N; Lomas DA; MacNee W; Miller B; Rennard SI; Silverman EK; Yates JC; Tal-Singer R;
    Am J Respir Crit Care Med; 2014 May; 189(9):1022-30. PubMed ID: 24552242
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.